Cancer. Developing molecular biomarkers for cancer.

doi:10.1126/science.1083158

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Cancer. Developing molecular biomarkers for cancer.

Science (New York, N.Y.) - 14 Mar 2003

Ransohoff David F

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colon
Share to Gene Silencing
Share to Genomic Imprinting
Share to Insulin-Like Growth Factor II

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Intestinal Mucosa

Share to Mass Spectrometry

Share to Proteome

Share to Proteomics

Source

Open in PubMed

Identifiers

PMID: 12637728
DOI: 10.1126/science.1083158

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancer. Developing molecular biomarkers for cancer.PMID 12637728Read ↗

Molecular markers of cancer.Semantic proximity Read ↗

Molecular assessment of cancer.Semantic proximity Read ↗

Molecular methods for the diagnosis of cancer.Semantic proximity Read ↗

Cancer molecular markers: A guide to cancer detection and management.Semantic proximity Read ↗

Medicine. Personalized cancer diagnostics.Semantic proximity Read ↗

Diagnostic and prognostic molecular markers in cancer.Semantic proximity Read ↗

Special report: multiple molecular testing of cancers to identify targeted therapies.Semantic proximity Read ↗

Molecular biomarkers for cancer detection in blood and bodily fluids.Semantic proximity Read ↗

Emerging molecular technologies for identifying the risk of second cancers.Semantic proximity Read ↗

Cancer genes and molecular oncology in the clinic.Semantic proximity Read ↗

Advances in cancer detection.Semantic proximity Read ↗

Emerging molecular markers of cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.